loader
Please Wait
Applying Filters...

Details of Shire Human Genetic Therapies Inc's U.S. FDA Inspections. Original Data: FDA Inspection Database

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11SHIRE HUMAN GENETIC THERAPIES INC

02 3Shire Human Genetic Therapies Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

SHIRE HUMAN GENETIC THERAPIES INC

City : Cambridge

State : MA

Country/Area : US

Zip : 2139

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-01-11

blank

02

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

SHIRE HUMAN GENETIC THERAPIES INC

City : North Reading

State : MA

Country/Area : US

Zip : 1864

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-01-06

blank

03

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

SHIRE HUMAN GENETIC THERAPIES INC

City : North Reading

State : MA

Country/Area : US

Zip : 1864

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2011-02-16

blank

04

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

SHIRE HUMAN GENETIC THERAPIES INC

City : Lexington

State : MA

Country/Area : US

Zip : 2421

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-08-31

blank

05

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

SHIRE HUMAN GENETIC THERAPIES INC

City : Cambridge

State : MA

Country/Area : US

Zip : 02138-1100

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2009-11-20

blank

06

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

SHIRE HUMAN GENETIC THERAPIES INC

City : Cambridge

State : MA

Country/Area : US

Zip : 02138-1100

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2011-05-19

blank

07

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

SHIRE HUMAN GENETIC THERAPIES INC

City : Cambridge

State : MA

Country/Area : US

Zip : 02138-1100

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2013-08-05

blank

08

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

SHIRE HUMAN GENETIC THERAPIES INC

City : Lexington

State : MA

Country/Area : US

Zip : 2421

District : NWE

Center : CDER

Project Area : Bioresearch Monitoring

District Decision : No Action Indicated

Inspection End Date : 2012-04-02

blank

09

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

SHIRE HUMAN GENETIC THERAPIES INC

City : Cambridge

State : MA

Country/Area : US

Zip : 2139

District : NWE

Center : CDER

Project Area : Bioresearch Monitoring

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-01-07

blank

10

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

SHIRE HUMAN GENETIC THERAPIES INC

City : Lexington

State : MA

Country/Area : US

Zip : 2421

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-02-01

blank